✦ LIBER ✦

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

✍ Scribed by Han, S-W; Oh, D-Y; Im, S-A; Park, S R; Lee, K-W; Song, H S; Lee, N-S; Lee, K H; Choi, I S; Lee, M H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6075 A triple combination of Imatinib, B

✍ Pessino, A.; Andretta, V.; Guglielmi, A.; Mammoliti, S.; Caprioni, F.; Fornarini 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Modified FOLFOX-6 chemotherapy in advanc

✍ Bhumsuk Keam; Seock-Ah Im; Sae-Won Han; Hye Seon Ham; Min A Kim; Do-Youn Oh; Se- 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 516 KB

A phase I study of sunitinib combined wi

✍ Leong, S.; Eckhardt, S. G.; Chan, E.; Messersmith, W. A.; Spratlin, J.; Camidge, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 244 KB

A multicenter phase II study of inductio

✍ De Vita, F; Orditura, M; Martinelli, E; Vecchione, L; Innocenti, R; Sileni, V C; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 316 KB

6566 A multicenter phase II study of ind

✍ De Vita, F.; Vecchione, L.; Orditura, M.; Innocente, R.; Farella, A.; Morgillo, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Prospective phase II study of neoadjuvan

✍ Jun Ho Ji, Se Hoon Park, Jeeyun Lee, Tae Won Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 228 KB